AstraZeneca signs deal for oral obesity drug and lifts profit outlook

Anglo-Swedish drugmaker’s oncology and rare disease medication sales offset waning demand for Covid jabs
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news